Company / Revenue per Share
4D Molecular Therapeutics, Inc. Revenue per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.00
FY2025
5-year range
$0.00 / $0.56
FY2021-FY2025
Trend
-99.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 6 years, ranging from $0.00 in FY2025 to $1.35 in FY2020.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -77.3%.
Declined from $0.10 to $0.00 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -88.7%
- 5-Year CAGR
- -77.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share decreased 99.8% year-over-year.
- Peak revenue per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -99.8% |
| FY2024 | $0.48 | +401.6% |
| FY2023 | $0.10 | -82.9% |
| FY2022 | $0.56 | +9.7% |
| FY2021 | $0.51 | -62.2% |
| FY2020 | $1.35 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026